Statistical Considerations
A sample size of 57 participants in each arm was estimated to produce a 95% confidence interval (CI) of 72%–92%, assuming the proportion achieving virologic suppression of 82% at week 24 (as achieved in the dolutegravir arm of the DAWNING study [